Using WHI Outcomes Data. Rebecca Hunt September 9, 2016
|
|
|
- Malcolm McLaughlin
- 6 years ago
- Views:
Transcription
1 Using WHI Outcomes Data Rebecca Hunt September 9, 2016
2 Focus on: What has been collected in WHI Which outcomes are adjudicated Changes between WHI and the extension studies (WHIX1 and WHIX2) What data is available on the WHI website Format How to use
3 Clinical Outcomes in the CT Defined as: primary or secondary Each study component (HT, DM, CaD) has 1 or 2 primary, and multiple secondary
4 Clinical Outcomes in the OS Same process for outcomes collection as in the CT No primary/secondary designation Fewer outcomes are adjudicated
5 Adjudication and Confirmation Most outcomes start as a self-report on Form 33 Form 33D used to collect more information Defined set of medical records obtained for selected outcomes Adjudication process confirms or denies the self-report (two levels: local and central)
6 Cardiovascular Outcomes, WHI Outcome HT DM CaD OS Form Cardiovascular: Coronary heart disease 1º - C 2º - L L L 121 Stroke 2º - C 2º - L L C 121/132 Congestive heart failure 2º - C 2º - L L L 121 Angina 2º - C 2º - L L L 121 Peripheral vascular disease 2º - C 2º - L L L 121 Carotid artery disease L L L L 121 Coronary revascularization 2º - C 2º - L L L 121 Total cardiovascular 2º 2º
7 Cancer Outcomes, WHI Outcome HT DM CaD OS Form Breast cancer 2º - C 1º - C 2º - C C 122/130 Endometrial cancer 2º - C 2º - C C C 122/130 Colorectal cancer C 1º - C 2º - C C 122/130 Ovarian cancer 2º - C 2º - C C C 122/130 Other cancer L L L L 122 Total cancer 2º 2º 2º
8 Fracture Outcomes, WHI Outcome HT DM CaD OS Form Hip fracture 2º - C C 1º - C C 123 Other fractures 2º - L L 2º - L L* 123 Total fractures 2º 2º * Only for participants at the 3 BMD clinical centers
9 Other Outcomes, WHI Outcome HT DM CaD OS Form Pulmonary embolism 2º - C 126 Deep vein thrombosis 2º - C 126 Diabetes mellitus requiring therapy S 2º - S S S 33 Death from any cause 2º - C 2º - C 2º-C L 124 1º - Primary outcome 2º - Secondary outcome C Centrally adjudicated L Locally adjudicated S Self-report
10 Self-reported Outcomes Source: Form 33 v. 5, question 8 Since the date given on the front of this form, has a doctor told you for the first time that you have any of the following specific conditions? Glaucoma, osteoporosis, osteoarthritis, rheumatoid arthritis, intestine or colon polyps or adenomas, gallbladder disease or gallstones, lupus, kidney or bladder stones, cataracts
11 Self-reported Outcomes (cont) Source: Form 33 v. 5, question 9 Since the date given on the front of this form, has a doctor prescribed for the first time any of the following pills or treatments? Pills for diabetes, insulin shots for diabetes, pills for high blood pressure
12 Other Sources of Outcomes Data ECG results (CT only) BMD results from DEXA (subset of CT & OS at 3 clinical centers) Form 33, question 3 (falls), question 10 (exams, tests, and procedures) OS follow-up questionnaires (Form 48, Forms ) 19 conditions
13 Some Changes in outcome data (WHI vs WHIX1 vs WHIX2) There are no local adjudications in WHIX1/WHIX2, all adjudications are done centrally Angina and CHF were locally adjudicated in WHI, they are only self-reported in WHIX1/WHIX2 (though we now have UNC HF adjudicated for the MRC Supercohort throughout WHI/WHIX1/WHIX2) Deaths central (CT) and local (OS) adjudications during WHI; central only during WHIX1; central (MRC) and self-report (SRC) during WHIX2 National Death Index (NDI) deaths Fracture only hip fracture is adjudicated in WHIX1/WHIX2, all other fractures are self-report (fracture was adjudicated in the CT & OS BMD clinics in WHI) Some endpoints were only collected in WHI (e.g., ECG data) and a few endpoints were added during WHIX2 (atrial fibrillation, heart valve disease, aortic aneurysm/dissection)
14 Some Changes in outcome data (WHI vs WHIX1 vs WHIX2) (cont)
15 Some Changes in outcome data (WHI vs WHIX1 vs WHIX2) (cont)
16 Data on the WHI website Visit forms, clinical measures, and other study data (baseline and follow-up visits) Clinical outcomes and detail data files (Currently through Sep 2015 includes extension study data)
17 September 2015 Outcomes Data on the WHI website Clinical outcomes and detail data files: Adjudicated outcomes (CT+OS, CaD) Self-reported outcomes (CT+OS, CaD, MRC, SRC) F121 cardiovascular detail (CT+OS, CaD) F121/132 stroke/cad detail (CT+OS, CaD) F122/130 cancer detail (CT+OS, CaD) F122/130 breast cancer detail (CT+OS, CaD) F123 fracture detail (CT+OS, CaD) F124 death & all discovered death detail (CT+OS) F126 DVT/PE detail (HT) F131 Hysterectomy (HT) UNC heart failure detail (MRC Supercohort) Aging (Survival) (CT+OS) (Corresponding.dat,.sas, and.pdf files)
18 CaD Trial Outcomes 91% of CaD participants were randomized at year 1 of the CT 8% at year 2 of the CT 1 % at other visits Timing of events in CaD participants uses CaD randomization date as the starting point
19 Format of data for each outcome (adjudicated outcomes file, outc_ct_os_inv.dat) Three variables: Indicator that outcome occurred (yes/no) Days from randomization/enrollment to date of outcome Source of adjudication (local, central, cause of death, ECG) IMPORTANT: Outcomes are first occurrence only Outcome from best adjudication only
20
21 Format of detail data files One row per participant, per outcome (participants may have multiple rows) Variable indicating ascertainment source (central or local) Flags for each outcome included in the file (yes/no) Form level detail items
22 Actual Data ID ASCSOURCE ANGINA AANEUR ADISSECT AFIBR CABG CHF MI CREVASC HEARTVALVE PERIPH PTCA ECGPATTR CARDENZY
23 Uses of Outcome Variables Get counts of outcomes (event flags include COD only events) Compare timing of events using days variables In time-to-event analyses (survival)
24 Example 1: select form 121 detail info for all clinical MI events and create time-to-event variable Read in pertinent datasets Form 121 data (outc_cardio_inv.dat) select rows where MI = 1. Variables to keep: ID, MI, MIDX, MIPROCTYP, etc. Adjudicated outcomes file (outc_ct_os_inv.dat). Variables to keep: ID, MI, MIDY, MISRC and ENDWHIDY, ENDEXT1DY or ENDFOLLOWDY. Merge the subsetted Form 121 file with the subsetted adjudicated outcomes file by participant id. Create time-to-event variable: => had event (MI = 1): misurvtm = MIDY => no event (MI = 0), censored (follow-up ends because of death or last contact): misurvtm = ENDFOLLOWDY
25 Example 2: using the breast cancer dataset
26 Example 2: using the breast cancer dataset
27 Example 2: using the breast cancer dataset The N s for invasive breast cancer in the adjudicated outcomes file and the breast cancer detail file do not match. The detail file only contains events that were adjudicated, it does not contain events only found through cause of death. Set up an analysis file for invasive breast cancer just as described for MI in Example 1. Descriptions for the ICD-O-2 codes and histology codes are contained in separate files and will also need to be merged with your dataset (merging on ICD-O-2 code and histology code, respectively).
28 Final thoughts Each time we release an updated set of outcome files, we remove the prior set from the website, so download all files at one time, including the corresponding data prep document Documentation is on the WHI website for outcome definitions and entire adjudication process Always study the forms associated with the data you are using to be sure you are grabbing the correct variables Other useful sources of information: Data Preparation and Use document, Outcomes chapter in the baseline monograph, several links on the Dataset Documentation web page
WHI Extension Appendix A, Form 33D Medical History Update (Detail) (Ver. 9) Page 1
WHI Extension Appendix A, Form 33D Medical History Update (Detail) (Ver. 9) Page 1 FORM: 33D - MEDICAL HISTORY UPDATE (Detail) Version: 9 March 30, 2007 Description: When used: Self-administered or interviewer-administered;
All Discovered Death Outcome Detail (Form 124/120)
This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877
Extension Study 2, Self Reported, Non-Adjudicated Outcomes for MRC Participants
Extension Study 2, Self Reported, on-adjudicated Outcomes for s File ame A self report is only counted if the first report of that outcome occurred after the start of the extension 2 phase of the study.
How much do you know about illnesses or health problems for your parents, grandparents, brothers, sisters, and/or children? 1 A lot Some None at all
Family Health History Please answer each question as honestly as possible. There are no right or wrong answers to nay of the questions. It is important that you answer as many questions as you can. We
February 25, WHI Heart Failure Data Summary. A. Original WHI outcome (referred to as CHF)
February 25, 2014 WHI Heart Failure Data Summary A. Original WHI outcome (referred to as CHF) Process: Sample: Collected and centrally adjudicated for HT participants and locally adjudicated on all non-ht
WHI Extension Section 8 Outcomes
8.6 Page 8-29 Physician Adjudicati on A WHI Extension Study outcome is adjudicated by assigning the appropriate outcome diagnosis based on Extension Study-defined criteria for each condition and recording
Women s Health Study Matrix of Variables Collected
Women s Health Study Matrix of Variables Collected 1. Demography DOB SS# Marital status Gender Race Profession Education NHS participant Income Employment status Phone number Contacts 2. Anthropometry
Data Preparation and Use of WHI Investigator Datasets Posted on the WHI Website (www.whi.org)
Data Preparation and Use of WHI Investigator Datasets Posted on the WHI Website (www.whi.org) Latest Update: June 30, 2017 (Data as of February 28, 2017) Table of Contents 1. Introduction... 2 1.1 Changes
Women s Health Initiative 2017 Annual Progress Report Data as of: February 28, 2017
Women s Health Initiative 2017 Annual Progress Report Data as of: February 28, 2017 The data, if any, contained in this report/deliverable are preliminary and may contain unvalidated findings. These data
WHI Extension - Appendix A, Form 33/33D - Medical History Update (Ver. 11) Page 1
WHI Extension - Appendix A, Form 33/33D - Medical History Update (Ver. 11) Page 1 FORM: 33 - MEDICAL HISTORY UPDATE Version: 11 October 1, 2010 Description: When used: Purpose: Self-administered or interviewer-administered;
WHI - Volume 3, Form 32 - Family History Questionnaire (Ver. 3) Page 1. Self-administered; 12-page booklet; data entered at Clinical Center (CC).
WHI - Volume 3, Form 32 - Family History Questionnaire (Ver. 3) Page 1 FORM: 32 - FAMILY HISTORY QUESTIONNAIRE Version: 3 - June 1, 1995 Description: When used: Purpose: Self-administered; 12-page booklet;
NEUROSURGERY PATIENT INTAKE FORM
NEUROSURGERY PATIENT INTAKE FORM Surgical Movement Disorders Center Name: DOB: / / Age: Gender: Male Female (circle one) Height: feet inches Weight: lbs What is the main reason for your visit? Are there
Evolve180 / Ideal Northwest Health Profile
Evolve180 / Ideal Northwest Health Profile ABOUT YOU First Name: Last Name: Address: City: State: Zip: Phone: Email: Date of Birth: Age: Height: Occupation: How did you find out about our program? Marital
Adult Health History
Patient Name Date of Birth Adult Health History This form will assist us in obtaining a complete medical history and health record on you. By completing this ahead of time it will also simply your visit
Intensity: 0-10 (10 is the worse pain you have ever experienced in your life that you would want to jump from a building, 0 is no pain)
Patient Questionnaire: Name: Date: Occupation: Date of Birth: Age: Sex: Male Female Referring Physician: Chief Complaint: Describe your Pain: sudden onset gradual constant intermittent worsening improving
Form 2 - Eligibility Screening
ID WHI Common ID Col#1 F2DAYS F2 Days since randomization Col#2 N Missing Min Max Mean Std Dev 0-1753 1107-145.472 153.960 F2CONT Contact type Col#3 The method used to collect the data. 1 Phone 65,083
WHI Medicare Data. Joe Larson, Roberta Ray, Mary Pettinger September 9, 2016
WHI Medicare Data Joe Larson, Roberta Ray, Mary Pettinger September 9, 2016 Outline Linkage between WHI and Medicare What is available on the Virtual Data Enclave (VDE) WHI Medicare Publications Agreement
Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School
Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review
Comprehensive Patient History Form
Comprehensive Patient History Form Date: Name: D.O.B. Past Medical History: (check all that apply) Acid Reflux Cataracts Heart disease Migraines Alcohol or Drug Problem Colitis/Crohns Heart valve problems
In your own words, please write the reason you are here. Please be specific, putting in dates as necessary. Use the back of the form if needed.
Name: SS# In your own words, please write the reason you are here. Please be specific, putting in dates as necessary. Use the back of the form if needed. Patient Medical, Surgical and Family History Review
City State Zip. Cell Phone. Other Phone. Gender Male Female Status Single Married Divorced Widowed. Height Weight EXERCISE Yes No Times per Week
Patient Name (First Middle Last) Date of Birth Social Security # Address City State Zip Home Phone Work Phone Cell Phone Other Phone Email Place of Birth Occupation Retired Yes No Gender Male Female Status
DONE! You can now close the browser.
Visit My Doctor Online at kp.org/mydoctor. Prepare for your visit This form will help you prepare for your upcoming visit with your doctor. You can complete it on your computer (Mac or PC) and e-mail it
Screening tests. When you need them and when you don t
Screening tests When you need them and when you don t S creening tests help doctors look for diseases when you don t have symptoms. The tests can Screenings find problems early, when they are easier to
MEDICAL HISTORY. Previous Nephrologist. Medication taken Insulin Oral Both. Who manages your diabetes? Blindness Yes No Hearing Problems Yes No
MEDICAL HISTORY Please mark YES or NO and fill in appropriate blanks as needed Chronic Yes No If yes, year diagnosed Previous Nephrologist Transplant Yes No If yes, date Donor type Living Deceased Related
Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene)
EMA/679870/2014 Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene) This is a summary of the risk management plan (RMP) for Duavive, which details the measures
MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization
MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Anticoagulants A. Prescriptions That Require Prior Authorization Prescriptions for Anticoagulants
Population: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F2VNUM. Sas Label: Categories:
Data File: formdat Last Update: 4/6/ umber of Obs: 689 Participant ID ID Participant ID Study: Administration F Days since randomization/enrollment Min Max Mean Std Dev 689-753 7-454683 5396455 FDAYS F
MEDICAL HISTORY FORM FOR FOLLOW-UP
MEDICAL HISTORY FORM FOR FOLLOW-UP ID NUMBER: 0a) Date of Collection / / 0b) Staff Code Instructions: Whenever numerical responses are required, enter the number so that the last digit appears in the rightmost
SECTION I: ACTIVE DIAGNOSES. Active Diagnoses in the Last 7 Days
SECTION I: ACTIVE DIAGNOSES Intent: The items in this section are intended to code diseases that have a relationship to the resident s current functional status, cognitive status, mood or behavior status,
Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings
CMS-1345-P 174 Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings AIM: Better Care for Individuals 1. Patient/Care Giver Experience
Patient Information. Insurance Information
Thoracic Group, PA Hyperhidrosis Center at Thoracic Group PA Robert J. Caccavale, MD Jean-Philippe Bocage, MD (732) 247-3002 Patient Information Name: Date: Date of Birth: Social Security #: Street Address:
MEDICAL HISTORY FORM FOR FOLLOW-UP
MEDICAL HISTORY FORM FOR FOLLOW-UP ID NUMBER: 0a) Form Date... / / 0b) Staff Code... Instructions: Whenever numerical responses are required, enter the number so that the last digit appears in the rightmost
BUSINESS. Articles? Grades Midterm Review session
BUSINESS Articles? Grades Midterm Review session REVIEW Cardiac cells Myogenic cells Properties of contractile cells CONDUCTION SYSTEM OF THE HEART Conduction pathway SA node (pacemaker) atrial depolarization
Clinic Adult Patient Demographics
Clinic Adult Patient Demographics Patient s Name: Previous or Nickname: Sex: Male Female Social Security Number - - Date of Birth: Mailing Address: City State Zip Code Home Phone #: ( ) - May we leave
HRT and bone health. Management of osteoporosis and controversial issues. Delfin A. Tan, MD
Strong Bone Asia V. Osteoporosis in ASEAN (+), Danang, Vietnam, 3 August 2013 Management of osteoporosis and controversial issues HRT and bone health Delfin A. Tan, MD Section of Reproductive Endocrinology
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE. Cranial Health History Form
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE Cranial Health History Form Welcome to the Neurosurgery Department at Washington University. To help us treat you, please fill this form out completely. Your Name:
Eligibility. Information about you. Information about your agent Only complete this section if you have an agent
Visitors to Canada Detailed medical questionnaire Underwritten by CUMIS General Insurance Company, a member of The Co-operators group of companies. How to complete this form: Complete one form for each
PQRS 2015Applicable Measure Group Codes ICD-9 and ICD-10 diagnosis codes and CPT encounter and surgical codes
PQRS 2015Applicable Measure Group Codes ICD-9 and and CPT encounter and surgical codes Acute Otisis Externa (AOE) Measures Group Page 1 Asthma Measures Group Page 2 Coronary Artery Bypass Graft (CABG)
ANY FAMILY HISTORY OF ANEURYSM OR DVT?
NAME: D/O/B: DATE: MR# WHAT PROBLEM(S) BRINGS YOU HERE TODAY? WHO SENT YOU TO US? DOCTOR/OTHER WHICH DOCTOR? WHAT SURGERY HAVE YOU HAD AND WHEN? (LIST) 1. 2. 3. 4. 5. 6. 7. HOW MUCH ALCOHOL DO YOU DRINK
Detailed medical questionnaire Underwritten by Co-operators Life Insurance Company.
canadian expatriates visitors to canada inpatriates to canada Detailed medical questionnaire Underwritten by Co-operators Life Insurance Company. How to complete this form: Complete one form for each person
Following the health of half a million participants
Following the health of half a million participants Cathie Sudlow UK Biobank Scientific Conference London, June 2018 Follow-up of participants in very large prospective cohorts Aim: identify a wide range
THE WOMEN S HEALTH INITIAtive
ORIGINAL CONTRIBUTION JAMA-EXPRESS Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women Principal Results From the Women s Health Initiative Randomized Controlled Trial Writing
Cardiac Risk Assessment in the Preoperative period
Cardiac Risk Assessment in the Preoperative period Catherine Curley, MD May, 2017 Disclosures I am not a cardiologist! 1 Case 1 78 yo man presenting to the ED after mechanical fall on his driveway. Found
Patient Interview Form
Patient Interview Form Patient Information First Name: Date Of Birth: Last Name: Email Please check one as your preferred email for communications Personal: Work: Race Select one or more White Unknown
Patient Name: Date of Birth: Date of Visit (Today s Date): Date of Injury (if applicable): Occupation: Right or Left Handed: Referring Provider:
New Patient History & Intake Form Patient Information Patient Name: Date of Birth: Date of Visit (Today s Date): Date of Injury (if applicable): Occupation: Right or Left Handed: Referring Provider: Preferred
Patient Interview Form
Patient Interview Form Patient Information First Name: MRN: Age: Last Name: Date Of Birth: tes: Contact Preference Email Telephone call/leave message Patient declines to specify Email Please check one
Section HC [HEALTH CONDITIONS] Sequence: 3. Would you say that in general {your/sp s} health is excellent, very good, good, fair, or poor?
![Section HC [HEALTH CONDITIONS] Sequence: 3. Would you say that in general {your/sp s} health is excellent, very good, good, fair, or poor?](/thumbs/83/88245910.jpg "Section HC [HEALTH CONDITIONS] Sequence: 3. Would you say that in general {your/sp s} health is excellent, very good, good, fair, or poor?")
NHATS Round Section HC [HEALTH CONDITIONS] Sequence: 3 HCPRE HCPRE T ON FILE Let s start with some questions about {your/sp s} health. PRESS AND ENTER TO CONTINUE HC hchealth R HC OVERALL HEALTH CONDITION
Eligibility. Information about you. Information about your agent Only complete this section if you have an agent
Canadian Expatriates Visitors to Canada Inpatriates to Canada Detailed medical questionnaire Underwritten by CUMIS General Insurance Company, a member of The Co-operators group of companies. How to complete
Manitoba Primary Care Quality Indicators Full Guide Version 3.0 Quick Reference Summary
PREVENTION 2.01 Cervical Cancer 2.02 Colon Cancer 2.03 Breast Cancer 2.04 Dyslipidemia for Women 2.05 Dyslipidemia for Men Female 21-69 PAP 36 Percentage of female enrolled patients 21 to 69 years of age
Supplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
2018 MIPS Reporting Family Medicine
2018 MIPS Reporting Family Medicine Quality Reporting Requirements: Report on 6 quality measures or a specialty measure set Include at least ONE outcome or high-priority measure Report on patients of All-Payers
Professional International Study Management
Professional International Study Management Services Phase I Study Consulting Phase II-IV IV Study Conduct for Drugs and Devices Protocol Design and Development Study Feasibilities Site Identification,
2017 Eligible Measure Applicability (EMA) for Registry Data Submission of Individual Quality Measures
2017 Eligible Measure Applicability (EMA) for Registry Data Submission of Individual Quality Measures 07/17/2017 Page 1 of 10 QPP Clinically Related Measure Analysis Used in EMA Clinical Relation including
(For items 1-12, each question specifies mark one or mark all that apply.)
Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:
WARFARIN: PERI OPERATIVE MANAGEMENT
WARFARIN: PERI OPERATIVE MANAGEMENT OBJECTIVE: To provide an approach to the perioperative management of warfarin treated patients who require an elective or urgent surgery/procedure. To provide an approach
Primary Care Clinic Adult Patient Demographics
Primary Care Clinic Adult Patient Demographics Patient s Name: Previous or Nickname: Sex: Male Female Social Security Number - - Date of Birth: Mailing Address: City State Zip Code Home Phone #: ( ) -
Hormone therapy. Dr. med. Frank Luzuy
Hormone therapy Dr. med. Frank Luzuy Reasons for Initiating/Continuing HT* Menopause-Related Symptoms Osteoporosis, Bone Loss, Fracture Prevention Doctor Prescribed It, Told Me to Take It Cardiovascular
o Kidney Cancer o Liver Cancer o Tremor o Tuberculosis o B12 Deficiency o Esophageal Cancer o Liver Disease o Pituitary Tumor o Uterine o Neurological
Adult New Patient Registration PATIENT DOB: / / MONTH DAY YEAR PATIENT NAME: LAST FIRST MI o Abnormal Heartbeat Patient Medical History: Please mark all that apply o Chronic Headaches o Hepatitis C o Neuropathy
Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근
Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근 Case (2011, 5) 74-years old gentleman Exertional chest pain Warfarin with good INR control Ex-smoker, social(?)
HORMONE REPLACEMENT THERAPY
TRIALS OF HR RUTH (Barrett- Connor et al 29 ) JULY 2006 (Country) mean ± sd, range International trial 67.5 an Placebo component in 67.5 ± 6.7 women with Raloxifene or multiple 67.5 ± 6.6 risk factors
The American Experience
The American Experience Jay F. Piccirillo, MD, FACS, CPI Department of Otolaryngology Washington University School of Medicine St. Louis, Missouri, USA Acknowledgement Dorina Kallogjeri, MD, MPH- Senior
Health History Questionnaire
Health History Questionnaire Page 1 of 8 Thank you for choosing Martin s Point to be your partner in health. To help us give you the highest-quality care, please answer the questions on this form as well
Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
Archived SECTION 18 - DIAGNOSIS CODES. Section 18 - Diagnosis Codes 18.1 GENERAL INFORMATION PRIOR CONTENTS NO LONGER APPLICABLE...
SECTION 18 - DIAGNOSIS CODES 18.1 GENERAL INFORMATION... 2 18.2 PRIOR CONTENTS NO LONGER APPLICABLE... 2 18.3 DIAGNOSIS CODE LISTING... 2 Ambulance Manual 1 SECTION 18 DIAGNOSIS CODES 18.1 GENERAL INFORMATION
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin. The WHI Investigators
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin The WHI Investigators 1 Background: WHI Hormone Program Design YES N= 10,739 Conjugated equine estrogen
Risk Adjustment and Hierarchical Condition Category Coding
Risk Adjustment 101 Agenda Risk Adjustment Model Hierarchical Condition Categories (HCC) Patient Example Documentation MEAT Documentation Guidance Chronic Conditions Risk Score Calculations Steps for Physician
Term & Universal Life Guidelines - Simplified
- G.U.L. AIDS Alcoholism Within past 4 years: Within past 4 years: Within past 5 years: After 5 years, without relapse, no current use: : After 5 years since treatment: Less than 5 years: POSSIBLE STANDARD
When Should I Order a Stress Test or an Echocardiogram
When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular
Chronic Obstructive Pulmonary Disease (COPD) Comorbidities Network
Chronic Obstructive Pulmonary Disease (COPD) Comorbidities Network Miguel J. Divo MD, Ciro Casanova MD, Jose M. Marin MD, Victor M. Pinto-Plata MD, Juan P. de-torres MD, Javier Zulueta MD, Carlos Cabrera
Chapter 4: Cardiovascular Disease in Patients with CKD
Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%
Summary of the risk management plan (RMP) for Senshio (ospemifene)
EMA/736568/2014 Summary of the risk management plan (RMP) for Senshio (ospemifene) This is a summary of the risk management plan (RMP) for Senshio, which details the measures to be taken in order to ensure
THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE
THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE Washington University grants permission to use and reproduce the The Importance of Comorbidity
Quality Measures MIPS CV Specific
Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from
The Association between Hemoglobin Concentrations and Cardiovascular Disease in Postmenopausal Women within the Women's Health Initiative
The Association between Hemoglobin Concentrations and Cardiovascular Disease in Postmenopausal Women within the Women's Health Initiative Item Type text; Electronic Dissertation Authors Wu, Guanglin Publisher
New Patient Packet. Patient Name: DOB: Age: Address: City: State: Zip: Address: City: State: Zip: Name: Address: Phone: Fax:
New Patient Packet Patient Name: DOB: Age: Sex: Male / Female Height: Weight: PHYSICIAN CARE Primary Care Physician: Address: City: State: Zip: Phone: Fax: Referring Physician (if different from PCP):
Selected tables standardised to Segi population
Selected tables standardised to Segi population LIST OF TABLES Table 4.2S: Selected causes of death, all-ages, 2000 2004 (Segi Standard) Table 5.3S: Public hospitalisations by major cause of admission
Validating and Grouping Diagnosis
Validating and Grouping Diagnosis DataSci Consulting CMS SAS User Group Conference, 2007 Grouping Grouping Grouping Goals Cover basic concepts about diagnoses and codes Share some examples Provide useful,
PATIENT INFORMATION. Name: First Name MI Last Name. Date of Birth: / / Sex: Male / Female / Declined SSN:
PATIENT INFORMATION Name: First Name MI Last Name Date of Birth: / / Sex: Male / Female / Declined SSN: Race: Ethnicity: Hispanic/Latino Not Hispanic/Latino Declined Marital Status: Single Married Divorced/Separated
CLINICIAN INTERVIEW CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL WOMEN
CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL WOMEN Nanette K. Wenger, MD, is a recognized authority on women and coronary heart disease. She chaired the US National Heart, Lung, and Blood Institute conference
Figure 1: Consort diagram; the status of participants in the study
Figure : Consort diagram; the status of participants in the study Figure a. Time to first colorectal cancer in those randomized to aspirin compared with those randomized to aspirin placebo (AP). Kaplan-Meier
The Muscatine Study Heart Health Survey
The Muscatine Study Heart Health Survey PARTICIPANT ID LABEL (include study ID, name, DOB, gender) Today s Date: - - (MM-DD-YYYY) Thank you for agreeing to participate in the International Childhood Cardiovascular
Selected Overweight- and Obesity- Related Health Disorders
Selected Overweight- and Obesity- Related Health Disorders HIGHLIGHTS Obesity and overweight are predisposing factors for the development of type 2 diabetes mellitus, coronary heart disease, stroke, osteoarthritis
Patient Information. Patient Name: DOB: Last First M.I. Home Address: City: State: Zip: Home Phn: Cell Phn: Alt. Phn: SSN:
Dr. Alvin Huang, M.D., F.A.C.E. 1650 W. Rosedale St. Suite 301, Fort Worth TX 76104 (P) 817-259-4333 (F) 817-820-0303 Patient Information Patient Name: DOB: Last First M.I. Home Address: City:_ State:
PREAMBLE GENERAL DIAGNOSTIC RADIOLOGY
PREAMBLE The General Diagnostic Radiology category is intended to cover the body of knowledge a practicing board certified Diagnostic Radiologist should know. Since the range of content relevant to the
b. To facilitate the management decision of a patient with an equivocal stress test.
National Imaging Associates, Inc. Clinical guidelines EBCT HEART CT & HEART CT CONGENITAL CCTA CPT4 Codes: 75571 EBCT 75572, 75573 Heart CT & Heart CT Congenital 75574 - CCTA LCD ID Number: L33559 J K
2016 General Practice/Family Practice Preferred Specialty Measure Set
1 0059 5 0081 41 N/A 50 N/A 65 0069, EHR 66 0002, EHR Effective Clinical Care Effective Clinical Care Effective Clinical Care Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%): Percentage of patients
Taking a medicine to reduce the chance of developing breast cancer
Patient decision aid Taking a medicine to reduce the chance of developing breast cancer Decision aid for postmenopausal women at high risk Published: March 2017 About this decision aid This decision aid
MER Baseline Enrollment Questionnaire. To be completed by Participant at time of Enrollment
MER Baseline Enrollment Questionnaire To be completed by Participant at time of Enrollment Mayo Clinic Return to: Lymphoma/CLL Study Coordinators Charlton 6 Internal Ext: 87039 1-800-610-7093 Instructions:
Welcome to the Healthplex!
Welcome to the Healthplex! Program Please check program that applies to you. If unsure, please ask our staff. Aftercare Employee Health Pulmonary Rehab Lung Gym Cardiac Rehab Health Improvement Prenatal/Post-Partum
*** ADDRESS: (If address is not provided, you MUST write Patient denied.)
PATIENT INFORMATION NORTHWEST BROWARD ORTHOPAEDICS DATE: ***E-MAIL ADDRESS: (If e-mail address is not provided, you MUST write Patient denied.) Pharmacy Name: Pharmacy Phone Number: Pharmacy Location PATIENT
(Title) First Name MI Last Name Maiden Name Suffix. What do you prefer to be called?
516 South Division Street, Suite 105 Cedar Falls, IA 50613-2381 Tel 319.268.3990 Fax 319.268.3995 Patient Demographic Information: Date (Title) First Name MI Last Name Maiden Name Suffix What do you prefer
ICD-9-CM CODING FUNDAMENTALS CODING EXERCISES
Steps to Accurate Coding Underline the main term, then locate code: Stenosis of Carotid Artery Transient Ischemic Attack Gastrointestinal hemorrhage Degenerative Joint Disease Coronary Artery Disease Alcoholic
Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology
Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations
New Antithrombotic and Antiplatelet Drugs in CAD : (Factor Xa inhibitors, Direct Thrombin inhibitors and Prasugrel)
New Antithrombotic and Antiplatelet Drugs in CAD : (Factor Xa inhibitors, Direct Thrombin inhibitors and Prasugrel) Limitations and Advantages of UFH and LMWH Biological limitations of UFH : 1. immune-mediated
WARFARIN: PERI-OPERATIVE MANAGEMENT
WARFARIN: PERI-OPERATIVE MANAGEMENT OBJECTIVE: To provide an approach to the perioperative management of warfarin-treated patients who require an elective or urgent surgery/procedure. To provide an approach
CHRONIC MEDICINE PROGRAMME: GENERAL INFORMATION LETTER
CHRONIC MEDICINE PROGRAMME: GENERAL INFORMATION LETTER The Prescribed Minimum Benefit Chronic Disease List In terms of the Medical Scheme Act Regulations that came into effect on 1 January 2004, Medical
- YOUR HEALTH HISTORY - (PLEASE COMPLETE ALL PAGES )
NAME (Please Print) First Name M.I. Last Name DATE of BIRTH / / - YOUR HEALTH HISTORY - (PLEASE COMPLETE ALL PAGES ) Exam Date:,20 PRESCRIPTIONS DRUGS Please Print MEDICATIONS NAMES ONLY NO PRESCRIPTION
Stroke/Carotid Artery Disease Outcome Detail (Form 121/132)
In Ext2 these outcomes are only adjudicated for Medical Record Cohort (MRC) ppts. ID WHI Participant Common ID Col#1 ASCSOURCE Ascertainment Source Col#2 1 Local Form 121 1,112 14.4 2 Central Form 121
Medication Allergies
**PLEASE CHECK IN 15 MINUTES PRIOR TO APPOINTMENT WITH FORMS COMPLETED** Primary Provider at Ocotillo Internal Medicine Other Physicians you see: Jonathan Hackenyos, D.O. 1. Cheryl Maurice, M.D. 2. 3.
8 th ANNUAL CLINICAL CARDIOLOGY COURSE Nashville, TN
8 th ANNUAL CLINICAL CARDIOLOGY COURSE Nashville, TN Mark your Calendar for July 26-29, 2018 to Attend the Only Available Comprehensive Review of Clinical Cardiology Practice designed for Nurse Practitioners